Evidence map›Paper›PMID 40274371›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Multicycle Dosimetric Behavior and Dose-Effect Relationships in [

Gunjan Kayal, Molly E Roseland, Chang Wang, Kellen Fitzpatrick, David Mirando, Krithika Suresh, Ka Kit Wong, Yuni K Dewaraja

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Fraction-dependent dose dynamics and clinical safety in high-risk neuroblastoma treated with [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. Patient Survival and Its Relation to Tumor Absorbed Dose in [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  4. Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response toJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. Rational Radionuclide Therapy for Recurrent Meningioma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gunjan KayalDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Molly E RoselandDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Chang WangDepartments of Biostatistics and Radiation Oncology, University of Michigan, Ann Arbor, Michigan; and.
Kellen FitzpatrickDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
David MirandoMIM Software, GE HealthCare, Cleveland, Ohio.
Krithika SureshDepartments of Biostatistics and Radiation Oncology, University of Michigan, Ann Arbor, Michigan; and.
Ka Kit WongDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Yuni K DewarajaDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan; yuni@umich.edu.

Funding

Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine ClinicR01CA240706 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2020 to 2024
$3.0M
NCI NIH HHS R01 CA240706
6 · The paper itself

Abstract

We investigated pharmacokinetics, dosimetric patterns, and absorbed dose (AD)-effect correlations in [

Indexed as

Neuroendocrine TumorsOctreotideOrganometallic CompoundsReceptors, PeptideAdultAgedDose-Response Relationship, RadiationFemaleHumansKidneyMaleMiddle AgedRadiometryRadiotherapy DosageSingle Photon Emission Computed Tomography Computed Tomographylutetium Lu 177 dotatateOctreotideOrganometallic CompoundsReceptors, Peptide177Lu-DOTATATEdose toxicitydosimetryradiopharmaceutical therapytheranostics

Identifiers

PMID40274371
PMCPMC12175996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.